Harvard University-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2020

  1. Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer’s disease

    Nature Communications, Vol. 11, Núm. 1

2012

  1. Reducing available soluble β-amyloid prevents progression of cerebral amyloid angiopathy in transgenic mice

    Journal of Neuropathology and Experimental Neurology, Vol. 71, Núm. 11, pp. 1009-1017

2010

  1. Triflusal reduces dense-core plaque load, associated axonal alterations and inflammatory changes, and rescues cognition in a transgenic mouse model of Alzheimer's disease

    Neurobiology of Disease, Vol. 38, Núm. 3, pp. 482-491

2009

  1. Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice

    Journal of Neurochemistry, Vol. 109, Núm. 6, pp. 1636-1647

2007

  1. Antibody-mediated clearance of amyloid-β peptide from cerebral amyloid angiopathy revealed by quantitative in vivo imaging

    Journal of Neuroscience, Vol. 27, Núm. 8, pp. 1973-1980

2006

  1. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease

    Neurobiology of Disease, Vol. 24, Núm. 3, pp. 516-524

  2. Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease

    Journal of Neuroscience, Vol. 26, Núm. 2, pp. 365-371